| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/26/2005 | CN1569029A Medicine for treating recurrent psoriasis and its preparing process |
| 01/26/2005 | CN1569022A Dripping pills of lentinan and its preparing process |
| 01/26/2005 | CN1569021A Enteric-coated azithromycin preparation and its preparing process |
| 01/26/2005 | CN1569016A Sustained release clarithromycin capsules and its preparation method |
| 01/26/2005 | CN1569015A Application of saponins in the preparing process of coxsackie virus resisting medicine |
| 01/26/2005 | CN1569010A Etimicin sulfate preparation and its preparing method |
| 01/26/2005 | CN1569005A Enteric-coated formulation of glycyrrhizic acid and its salt and its preparing method |
| 01/26/2005 | CN1569000A Quick-acting and long-acting aliporina contained injection |
| 01/26/2005 | CN1568997A Antibacterial cooperated pharmaceutical composition |
| 01/26/2005 | CN1568996A Freeze dried formulation of ciprofloxacin hydrochloride and its preparation method |
| 01/26/2005 | CN1568983A Impurity content control technology of high polymer in the preparing process of amoxicillin capsule |
| 01/26/2005 | CN1568975A Preparing method of freeze-dried antibiotic formulation |
| 01/26/2005 | CN1568973A Composition of vitamin C and arginine and its application |
| 01/26/2005 | CN1568972A Dripping pills of armillarisin A and its preparation method |
| 01/26/2005 | CN1568970A Dripping pills of andrographolide and its preparing method |
| 01/26/2005 | CN1568968A Application of flavonol polyphenol in the preparing process of SARS treating medicine |
| 01/26/2005 | CN1568960A High purity chlorogenic acid prescription |
| 01/26/2005 | CN1568956A Compound diisopropylamine dichloroacetate powder and injection prreparations |
| 01/26/2005 | CN1568955A Compound diisopropylamine dichloroacetate transfusion liquid |
| 01/26/2005 | CN1568945A Application of curcumin to preparation of pharmaceutical for SARS |
| 01/26/2005 | CN1186448C Recombinant human alpha-prothymosin interleukin 2 gene and its expression and use |
| 01/26/2005 | CN1186339C Pyrimidinyl methyl indole derivatives with antibacterial activity |
| 01/26/2005 | CN1186328C Substd. 5-benzyl-2, 4-diaminopyrimidines |
| 01/26/2005 | CN1186322C Proline derivatives and use thereof as drugs |
| 01/26/2005 | CN1186091C Liver disease treating injection and its production process |
| 01/26/2005 | CN1186078C Medicine for treating common cold |
| 01/26/2005 | CN1186077C Medicine for stopping pain, diminishing inflammation, removing necrosis and promoting granulation |
| 01/26/2005 | CN1186075C Medicine for treating pulmonary tuberculosis |
| 01/26/2005 | CN1186073C Medicine for treating genital herpes and preparation process thereof |
| 01/26/2005 | CN1186068C Externally applied Chinese medicine with functions of diminishing inflammation, promoting granulation, stopping itch and stopping pain and its preparation process |
| 01/26/2005 | CN1186064C Medicine for treating hepatopathy and its preparation process |
| 01/26/2005 | CN1186062C Antiinflammatory hemostatic gynecologic medicine and use thereof |
| 01/26/2005 | CN1186061C Extracted herbal medicine for treating chicken infectious bursa of Fabricius |
| 01/26/2005 | CN1186052C Medicine for treatment of pelvic inflammation, its preparation and preparing method |
| 01/26/2005 | CN1186050C Ointment for removing necrosis, promoting granulation and invigorating bone and its preparation |
| 01/26/2005 | CN1186049C Odor-free garlic extract capsule and its preparing process |
| 01/26/2005 | CN1186042C Chinese medicine composition for treating AIDS and its preparation method |
| 01/26/2005 | CN1186037C Medicine for treating hepatitis |
| 01/26/2005 | CN1186025C Sodium foscarnet frozen dried preparation and process for preparing the same |
| 01/26/2005 | CN1186021C Antimicrobial composition |
| 01/26/2005 | CN1186013C Peroral medicine deliver controlled system providing temporal and spatial control |
| 01/26/2005 | CN1186010C Vegetable oil fatty milk oral or injection preparation |
| 01/25/2005 | US6846958 Synthesis of benzimidate from benzoic acid |
| 01/25/2005 | US6846954 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 01/25/2005 | US6846939 Minocycline compound substitued at 9-position by a group selected from nitro, alkyl, alkenyl, alkynyl, aryl, alkoxy, alkylthio, alkylsufinyl, alkylsulfonyl, amino, thionitroso, arylalkynyl or carbamate, urea, and sulfonamide |
| 01/25/2005 | US6846834 Antiinflammation agents |
| 01/25/2005 | US6846828 Aminopyrimidine and aminopyridine anti-inflammation agents |
| 01/25/2005 | US6846827 Antiinflammatory agents; antiallergens; antiarthritic agents |
| 01/25/2005 | US6846825 Antibacterial agents |
| 01/25/2005 | US6846819 Bactericides compound containing acrylamide group |
| 01/25/2005 | US6846810 Antiviral nucleoside derivatives |
| 01/25/2005 | US6846802 Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moieties |
| 01/25/2005 | US6846667 Virulence genes and proteins, and their use |
| 01/25/2005 | US6846651 Comprises sequence of influenza bacterial genome and position of proteins relative to specific restriction enzyme; diagnosis and treatment of respiratory disorders; genetic mapping |
| 01/25/2005 | US6846649 Recombinant human mannan-binding lectin |
| 01/25/2005 | US6846499 Medical effect of jojoba oil |
| 01/25/2005 | US6846485 Fish serine proteinase and their pharmaceutical and cosmetic use |
| 01/25/2005 | US6846477 One dose vaccination with Mycoplasma hyopneumoniae |
| 01/25/2005 | CA2133108C Pasteurella haemolytica type a-1 bacterin-toxoid vaccine |
| 01/25/2005 | CA2129455C Orally active azole derivatives |
| 01/25/2005 | CA2123224C Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
| 01/20/2005 | WO2005006807A1 Transmitter of wireless microphone, receiver for wireless microphone, mobile information communication apparatus, and communication system for wireless microphone |
| 01/20/2005 | WO2005006806A1 Wireless microphone communication system |
| 01/20/2005 | WO2005005632A2 SMALL INTERFERING RNA SPECIFIC TO SUB-UNITS $G(A), $G(A)' AND $G(B) OF THE KINASE PROTEIN CK2, AND THE APPLICATIONS OF THE SAME |
| 01/20/2005 | WO2005005466A2 Nucleic and protein sequences from the hxhv virus and uses thereof |
| 01/20/2005 | WO2005005456A2 Peptide deformylase inhibitors |
| 01/20/2005 | WO2005005443A1 Organosilicon compounds and their use |
| 01/20/2005 | WO2005005442A1 Silicon compounds and their use |
| 01/20/2005 | WO2005005436A2 Cross-linked glycopeptide-cephalosporin antibiotics |
| 01/20/2005 | WO2005005426A1 Isethionate salt of a selective cdk4 inhibitor |
| 01/20/2005 | WO2005005424A1 Aztreonam l-lysine and methods for the preparation thereof |
| 01/20/2005 | WO2005005422A1 Oxazolidinone antibiotics and derivatives thereof |
| 01/20/2005 | WO2005005420A1 Cyclopropyl group substituted oyazolidinone antibiotics and derivatives thereof |
| 01/20/2005 | WO2005005418A1 Benzofuran derivatives and their use in the treatment of microbial infections |
| 01/20/2005 | WO2005005399A1 Oxazolidinone antibiotics and derivatives thereof |
| 01/20/2005 | WO2005005398A2 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
| 01/20/2005 | WO2005005386A1 Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 01/20/2005 | WO2005005372A1 Compound having anti-hcv activity and process for producing the same |
| 01/20/2005 | WO2005004926A1 Dendritic cell infiltrativity activating composition and immune activator |
| 01/20/2005 | WO2005004914A1 MEDICINAL COMPOSITION CONTAINING NF-κB DECOY FOR TREATING AND PREVENTING RESPIRATORY DISEASES AND METHOD OF USING THE SAME |
| 01/20/2005 | WO2005004913A1 Pharmaceutical composition containing decoy and method of using the same |
| 01/20/2005 | WO2005004911A2 Adjuvant combinations of liposomes and mycobacterial lipids for immunization compositions and vaccines |
| 01/20/2005 | WO2005004904A1 Method for treating diseases associated with modifications of qualitative and/ quantitative composition of blood extracellular dna (variants) |
| 01/20/2005 | WO2005004898A1 Drug promoting ceramide transport, base sequence for producing the drug, method of measuring activity of promoting ceramide release and method of measuring activity of promoting intermembrane ceramide transfer |
| 01/20/2005 | WO2005004894A2 Methods for increasing cell and tissue viability |
| 01/20/2005 | WO2005004882A1 Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof |
| 01/20/2005 | WO2005004868A1 Anti-coronavirus drug |
| 01/20/2005 | WO2005004856A1 Antifungal composition |
| 01/20/2005 | WO2005004789A2 Method for treating diseases associated with changes of qualitative and/ quantitative composition of blood extracellular dna |
| 01/20/2005 | WO2004106411A3 Biodegradable poly(beta-amino esters) and uses thereof |
| 01/20/2005 | WO2004100995B1 Targeted delivery of anti-viral compounds through hemoglobin bioconjugation |
| 01/20/2005 | WO2004096194A9 Prevention of hiv-1 infection by inhibition of rho-mediated reorganization and/or content alteration of cell membrane raft domains |
| 01/20/2005 | WO2004089983A3 Severe acute respiratory syndrome (sars) causing coronavirus |
| 01/20/2005 | WO2004069142A3 Anti-candida agents for the treatment of prion diseases |
| 01/20/2005 | WO2004064742A9 Methods and compositions for p2x receptor calcium entry channels and other calcium entry mechanisms |
| 01/20/2005 | WO2004062674A3 Substituted polyamines as inhibitors of bacterial efflux pumps |
| 01/20/2005 | WO2003066881A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 01/20/2005 | WO2002050289A8 Methods for the production of multimeric proteins, and related compositions |
| 01/20/2005 | US20050014931 A monoclonal antibody or an antigen-binding fragment thereof that specifically binds the capsular polysaccharide of Streptococcus pneumoniae serotype PPS 3; heavy chain amino acid sequence as well as DNA encoding it; complementary determining regions; pneumonia; passive immunizations; diagnosis/medical/ |
| 01/20/2005 | US20050014930 Bactericide for mrsa |